SCHEMBL299042

SCHEMBL299042

CCc1c2n(c(=O)c3c(OC)c(OC)ccc13)CCc1cc3c(cc1-2)OCO3

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.63
P2RX7 Q99572 6/20 0.52
CYP2D6 P10635 4/20 0.48
KMT2A Q03164 3/20 0.48
ACHE P22303 3/20 0.45
CYP3A4 P08684 6/20 0.42
ALDH1A1 P00352 3/20 0.42
MAPT P10636 3/20 0.42
MEN1 O00255 2/20 0.42
HSD17B10 Q99714 2/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
ALOX12 P18054 1/20 0.42
MAPK1 P28482 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
TSHR P16473 3/20 0.41
LMNA P02545 2/20 0.41
CHRM1 P11229 2/20 0.41
DRD2 P14416 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL299656 0.88 BCHE (0.58) BCHEP2RX7CYP2D6KMT2AACHE
SCHEMBL18037451 0.88 BCHE (0.58) BCHEP2RX7CYP2D6KMT2AACHE
SCHEMBL297348 0.87 BCHE (0.66) BCHEP2RX7CYP2D6KMT2AACHE
SCHEMBL18037443 0.87 BCHE (0.56) BCHEP2RX7CYP2D6KMT2AACHE
SCHEMBL16884608 0.87 BCHE (0.56) BCHEP2RX7CYP2D6KMT2AACHE
SCHEMBL31472748 0.87 BCHE (0.65) BCHEP2RX7CYP2D6KMT2AACHE
SCHEMBL31472747 0.87 BCHE (0.65) BCHEP2RX7CYP2D6KMT2AACHE
SCHEMBL31472746 0.87 BCHE (0.65) BCHEP2RX7CYP2D6KMT2AACHE
SCHEMBL29823151 0.86 BCHE (0.56) BCHEP2RX7CYP2D6KMT2AACHE
SCHEMBL18037450 0.86 BCHE (0.56) BCHEP2RX7CYP2D6KMT2AACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2427460-B1 NOVEL ISOQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-26 EP disclosed
EP-2427460-B1 NOVEL ISOQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-26 EP disclosed
US-8258149-B2 Isoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2012-09-04 US disclosed
US-8258149-B2 Isoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2012-09-04 US disclosed
US-8258149-B2 Isoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2012-09-04 US disclosed
EP-2427460-A1 NOVEL ISOQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2012-03-14 EP disclosed
US-20100286396-A1 NOVEL ISOQUINOLINE DERIVATIVES HOFFMANN-LA ROCHE, INC. 2010-11-11 US disclosed
US-20100286396-A1 NOVEL ISOQUINOLINE DERIVATIVES HOFFMANN-LA ROCHE, INC. 2010-11-11 US disclosed
US-20100286396-A1 NOVEL ISOQUINOLINE DERIVATIVES HOFFMANN-LA ROCHE, INC. 2010-11-11 US disclosed
WO-2010128061-A1 NOVEL ISOQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2010-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286396-A1 NOVEL ISOQUINOLINE DERIVATIVES CYP3A7, RAB7A, IPO7 BCHE 3051/4885P2RX7 669/4885CYP2D6 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.